These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38164562)

  • 41. A tailored psychological intervention for anxiety and depression management in people with chronic obstructive pulmonary disease: TANDEM RCT and process evaluation.
    Sohanpal R; Pinnock H; Steed L; Heslop-Marshall K; Kelly MJ; Chan C; Wileman V; Barradell A; Dibao-Dina C; Font Gilabert P; Healey A; Hooper R; Mammoliti KM; Priebe S; Roberts M; Rowland V; Waseem S; Singh S; Smuk M; Underwood M; White P; Yaziji N; Taylor SJ
    Health Technol Assess; 2024 Jan; 28(1):1-129. PubMed ID: 38229579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating process and effectiveness of a low-intensity CBT intervention for women with gynaecological cancer (the EPELIT Trial).
    Hulbert-Williams NJ; Hulbert-Williams L; Flynn RJ; Pendrous R; MacDonald-Smith C; Mullard A; Swash B; Evans G; Price A
    AMRC Open Res; 2021; 3():12. PubMed ID: 38708072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT.
    Carrie S; Fouweather T; Homer T; O'Hara J; Rousseau N; Rooshenas L; Bray A; Stocken DD; Ternent L; Rennie K; Clark E; Waugh N; Steel AJ; Dooley J; Drinnan M; Hamilton D; Lloyd K; Oluboyede Y; Wilson C; Gardiner Q; Kara N; Khwaja S; Leong SC; Maini S; Morrison J; Nix P; Wilson JA; Teare MD
    Health Technol Assess; 2024 Mar; 28(10):1-213. PubMed ID: 38477237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
    Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
    Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
    Velikova G; Morden JP; Haviland JS; Emery C; Barrett-Lee P; Earl H; Bloomfield D; Brunt AM; Canney P; Coleman R; Verrill M; Wardley A; Bertelli G; Ellis P; Stein R; Bliss JM; Cameron D;
    Lancet Oncol; 2023 Dec; 24(12):1359-1374. PubMed ID: 37926100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
    Blagden SP; Cook AD; Poole C; Howells L; McNeish IA; Dean A; Kim JW; O'Donnell DM; Hook J; James EC; White IR; Perren T; Lord R; Dark G; Earl HM; Hall M; Kaplan R; Ledermann JA; Clamp AR
    Lancet Oncol; 2020 Jul; 21(7):969-977. PubMed ID: 32615110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors.
    Yun YH; Kim YA; Lee MK; Sim JA; Nam BH; Kim S; Lee ES; Noh DY; Lim JY; Kim S; Kim SY; Cho CH; Jung KH; Chun M; Lee SN; Park KH; Park S
    BMC Cancer; 2017 May; 17(1):298. PubMed ID: 28464804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study.
    Curigliano G; Dunton K; Rosenlund M; Janek M; Cathcart J; Liu Y; Fasching PA; Iwata H
    Ann Oncol; 2023 Jul; 34(7):569-577. PubMed ID: 37179020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
    Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
    Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of an online intervention for improving stroke survivors' health-related quality of life: A randomised controlled trial.
    Guillaumier A; Spratt NJ; Pollack M; Baker A; Magin P; Turner A; Oldmeadow C; Collins C; Callister R; Levi C; Searles A; Deeming S; Clancy B; Bonevski B
    PLoS Med; 2022 Apr; 19(4):e1003966. PubMed ID: 35439246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Holistic needs assessment and care plans for women with gynaecological cancer: do they improve cancer-specific health-related quality of life? A randomised controlled trial using mixed methods.
    Sandsund C; Towers R; Thomas K; Tigue R; Lalji A; Fernandes A; Doyle N; Jordan J; Gage H; Shaw C
    BMJ Support Palliat Care; 2020 Jun; 10(2):e16. PubMed ID: 28847853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial.
    Adlard KN; Jenkins DG; Salisbury CE; Bolam KA; Gomersall SR; Aitken JF; Chambers SK; Dunn JC; Courneya KS; Skinner TL
    BMC Cancer; 2019 Jul; 19(1):656. PubMed ID: 31269917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advice only versus advice and a physiotherapy programme for acute traumatic anterior shoulder dislocation: the ARTISAN RCT.
    Kearney R; Ellard D; Parsons H; Haque A; Mason J; Nwankwo H; Bradley H; Drew S; Modi C; Bush H; Torgerson D; Underwood M;
    Health Technol Assess; 2024 Apr; 28(22):1-94. PubMed ID: 38695098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries.
    Lamb SE; Williams MA; Williamson EM; Gates S; Withers EJ; Mt-Isa S; Ashby D; Castelnuovo E; Underwood M; Cooke MW;
    Health Technol Assess; 2012; 16(49):iii-iv, 1-141. PubMed ID: 23241145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
    Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment.
    Russell L; Gough K; Drosdowsky A; Schofield P; Aranda S; Butow PN; Westwood JA; Krishnasamy M; Young JM; Phipps-Nelson J; King D; Jefford M
    J Cancer Surviv; 2015 Sep; 9(3):462-70. PubMed ID: 25573722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L).
    Garcia Campelo MR; Lin HM; Zhu Y; Pérol M; Jahanzeb M; Popat S; Zhang P; Camidge DR
    Lung Cancer; 2021 May; 155():68-77. PubMed ID: 33744781
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.